Brian F. Issell

4.1k total citations · 2 hit papers
55 papers, 2.8k citations indexed

About

Brian F. Issell is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Brian F. Issell has authored 55 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 11 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Brian F. Issell's work include Lung Cancer Research Studies (8 papers), Global Cancer Incidence and Screening (7 papers) and Cancer therapeutics and mechanisms (6 papers). Brian F. Issell is often cited by papers focused on Lung Cancer Research Studies (8 papers), Global Cancer Incidence and Screening (7 papers) and Cancer therapeutics and mechanisms (6 papers). Brian F. Issell collaborates with scholars based in United States, United Kingdom and Canada. Brian F. Issell's co-authors include Stanley T. Crooke, Archie W. Prestayko, Eric J. Topol, Elizabeth O. Lillie, Nicholas J. Schork, Bradley Patay, Gerald P. Bodey, Raymond B. Weiss, Gary R. Morrow and Carolyn Gotay and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Brian F. Issell

54 papers receiving 2.6k citations

Hit Papers

The N-Of-1 Clinical Trial:... 1979 2026 1994 2010 2011 1979 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian F. Issell United States 25 991 589 367 311 277 55 2.8k
Julie L. Ryan United States 26 1.6k 1.6× 487 0.8× 253 0.7× 415 1.3× 638 2.3× 43 3.5k
Gil Bar‐Sela Israel 34 1.3k 1.3× 1.2k 2.0× 416 1.1× 324 1.0× 420 1.5× 199 4.5k
Judith A. Smith United States 33 565 0.6× 847 1.4× 177 0.5× 467 1.5× 167 0.6× 121 3.1k
Isabelle Bairati Canada 36 877 0.9× 635 1.1× 120 0.3× 504 1.6× 686 2.5× 100 3.5k
Nagi B. Kumar United States 34 1.3k 1.3× 949 1.6× 401 1.1× 165 0.5× 686 2.5× 93 3.7k
Yuqing Zhang China 26 453 0.5× 452 0.8× 445 1.2× 179 0.6× 212 0.8× 112 2.6k
E O’Brien Ireland 30 863 0.9× 696 1.2× 115 0.3× 558 1.8× 724 2.6× 96 4.0k
M L Slevin United Kingdom 38 1.8k 1.8× 1.1k 1.9× 256 0.7× 652 2.1× 628 2.3× 106 4.9k
B. J. Kennedy United States 38 1.4k 1.4× 784 1.3× 157 0.4× 992 3.2× 792 2.9× 135 4.1k
Gregory A. Curt United States 28 2.5k 2.5× 970 1.6× 304 0.8× 268 0.9× 1.0k 3.8× 62 5.3k

Countries citing papers authored by Brian F. Issell

Since Specialization
Citations

This map shows the geographic impact of Brian F. Issell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian F. Issell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian F. Issell more than expected).

Fields of papers citing papers by Brian F. Issell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian F. Issell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian F. Issell. The network helps show where Brian F. Issell may publish in the future.

Co-authorship network of co-authors of Brian F. Issell

This figure shows the co-authorship network connecting the top 25 collaborators of Brian F. Issell. A scholar is included among the top collaborators of Brian F. Issell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian F. Issell. Brian F. Issell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuno, Rayna K., Ian Pagano, Gertraud Maskarinec, Brian F. Issell, & Carolyn Gotay. (2012). Complementary and Alternative Medicine Use and Breast Cancer Prognosis: A Pooled Analysis of Four Population-Based Studies of Breast Cancer Survivors. Journal of Women s Health. 21(12). 1252–1258. 17 indexed citations
2.
Maskarinec, Gertraud, Ian Pagano, Galina Lurie, et al.. (2011). Factors Affecting Survival Among Women with Breast Cancer in Hawaii. Journal of Women s Health. 20(2). 231–237. 21 indexed citations
3.
Blanke, Charles D., Kari Chansky, Scott A. Hundahl, et al.. (2010). S9511. American Journal of Clinical Oncology. 33(2). 117–120. 5 indexed citations
4.
Issell, Brian F., Adrian A. Franke, & Robert M. Fielding. (2008). Pharmacokinetic Study of Noni Fruit Extract. Journal of Dietary Supplements. 5(4). 373–382. 20 indexed citations
5.
Mustian, Karen M., Jennifer J. Griggs, Gary R. Morrow, et al.. (2006). Exercise and side effects among 749 patients during and after treatment for cancer: a University of Rochester Cancer Center Community Clinical Oncology Program Study. Supportive Care in Cancer. 14(7). 732–741. 49 indexed citations
6.
Mustian, Karen M., Gary R. Morrow, Leslie Gillies, et al.. (2005). Prevalence of complementary and alternative medicine use in cancer patients during treatment. Supportive Care in Cancer. 13(10). 806–811. 245 indexed citations
7.
Maskarinec, Gertraud, et al.. (2002). The use of breast conserving surgery: linking insurance claims with tumor registry data. BMC Cancer. 2(1). 3–3. 13 indexed citations
8.
Gotay, Carolyn, et al.. (2000). Impact of a Culturally Appropriate Intervention on Breast and Cervical Screening among Native Hawaiian Women. Preventive Medicine. 31(5). 529–537. 77 indexed citations
9.
Ho, D H, et al.. (1985). Radioimmunoassay for etoposide and teniposide. Journal of Immunological Methods. 85(1). 5–15. 10 indexed citations
10.
Louie, Arthur C. & Brian F. Issell. (1985). Amsacrine (AMSA)--a clinical review.. Journal of Clinical Oncology. 3(4). 562–592. 53 indexed citations
11.
López, José A., et al.. (1985). Clinical pharmacology of intraperitoneal cisplatin. Gynecologic Oncology. 20(1). 1–9. 51 indexed citations
12.
Bradley, Edward C., Brian F. Issell, & Richard Hellman. (1984). The human tumor colony-forming chemosensitivity assay: A biological and clinical review. Investigational New Drugs. 2(1). 59–70. 20 indexed citations
13.
Issell, Brian F., J. J. Catino, & E C Bradley. (1984). Usefulness of the Human Tumor Colony Forming Assay for New Drug Development. Recent results in cancer research. 94. 237–244. 4 indexed citations
14.
Issell, Brian F., et al.. (1982). Dibromodulcitol plus bleomycin compared with bleomycin alone in head and neck cancer. Cancer Chemotherapy and Pharmacology. 8(2). 171–3. 3 indexed citations
15.
Weiss, Raymond B. & Brian F. Issell. (1982). The nitrosoureas: carmustine (BCNU) and lomustine (CCNU). Cancer Treatment Reviews. 9(4). 313–330. 102 indexed citations
16.
Issell, Brian F., Bruce V. MacFadyen, Elizabeth T. Gum, et al.. (1981). Serum zinc levels in lung cancer patients. Cancer. 47(7). 1845–1848. 43 indexed citations
17.
Issell, Brian F.. (1980). Amsacrine (AMSA). Cancer Treatment Reviews. 7(2). 73–83. 20 indexed citations
18.
Issell, Brian F., Michael J. Keating, Manuel Valdivieso, & Gerald P. Bodey. (1979). Continuous infusion tobramycin combined with carbenicillin for infections in cancer patients. The American Journal of the Medical Sciences. 277(3). 311–318. 20 indexed citations
19.
Issell, Brian F., Manuel Valdivieso, & Howard A. Zaren. (1978). Protection of chemotherapy toxicities by intravenous hyperalimentation (IVH). Proceedings of the American Association for Cancer Research. 19. 1 indexed citations
20.
Issell, Brian F. & Stanley T. Crooke. (1978). Maytansine. Cancer Treatment Reviews. 5(4). 199–207. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026